Background:
Punica granatum L. is an infructescence native of occidental Asia and Mediterranean
Europe, popularly referred to as pomegranate. It has been used in ethnomedicine for several applications, including
the treatment of obesity, inflammation, diabetes, and the regulation of blood lipid parameters. Thus, pomegranate
has been linked to the treatment of cardiovascular diseases that have endothelial dysfunction as a common
factor acting mainly against oxidative stress due to its high polyphenol content. Its biocomponents have antihypertensive,
antiatherogenic, antihyperglycemic, and anti-inflammatory properties, which promote cardiovascular
protection through the improvement of endothelial function.
Methods:
Different electronic databases were searched in a non-systematic way to uncover the literature of interest.
Conclusion:
This review article presents updated information on the role of pomegranate in the context of endothelial
dysfunction and cardiovascular diseases. We have shown that pomegranate, or rather its components (e.g.,
tannins, flavonoids, phytoestrogens, anthocyanins, alkaloids, etc.), have beneficial effects on the cardiovascular
system, improving parameters such as oxidative stress and the enzymatic antioxidant system, reducing reactive
oxygen species formation and acting in an anti-inflammatory way. Thus, this review may contribute to a better
understanding of pomegranate's beneficial actions on endothelial function and possibly to the development of
strategies associated with conventional treatments of cardiovascular diseases.